Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine

Chest

Volumn 151, Issue 1, 2017, Pages 181-192

  Dunham Snary, Kimberly J ^a   Wu, Danchen ^a   Sykes, Edward A ^a   Thakrar, Amar ^a   Parlow, Leah R G ^a   Mewburn, Jeffrey D ^a   Parlow, Joel L ^a   Archer, Stephen L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

chuvash polycythemia; high altitude pulmonary edema; mitochondria; oxygen sensitive potassium channels; single lung anesthesia; ventilation perfusion matching

Indexed keywords

CALCIUM ION; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; RHO KINASE; VASODILATOR AGENT; VOLTAGE GATED CALCIUM CHANNEL;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ALTITUDE DISEASE; ASTHMA; ATELECTASIS; CALCIUM CELL LEVEL; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHUVASH DISEASE; ENZYME ACTIVATION; EPIGENETICS; GENETICS; HUMAN; HYPOXEMIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG BLOOD FLOW; LUNG PERFUSION; LUNG VENTILATION; MEDICINE; METABOLISM; MITOCHONDRION; NONHUMAN; OXYGEN SENSING; PATHOGENESIS; PNEUMONIA; PULMONARY ARTERY; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; REVIEW; SENSOR; SEPSIS; THORAX SURGERY; HYPOXIA; LUNG CIRCULATION; LUNG GAS EXCHANGE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION;

HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN CONSUMPTION; PULMONARY CIRCULATION; PULMONARY GAS EXCHANGE; VASOCONSTRICTION;

EID: 85009785196     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.09.001     Document Type: Review

References (87)

1. 1 Bradford, J.R., Dean, H.P., The pulmonary circulation. J Physiol 16:1-2 (1894), 34–110.
2. 2 Euler, U.S.V., Liljestrand, G., Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12:4 (1946), 301–320.
3. 3 Madden, J.A., Dawson, C.A., Harder, D.R., Hypoxia-induced activation in small isolated pulmonary arteries from the cat. J Appl Physiol (1985) 59:1 (1985), 113–118.
4. 4 Baraka, A.S., Taha, S.K., Yaacoub, C.I., Alarming hypoxemia during one-lung ventilation in a patient with respiratory bronchiolitis-associated interstitial lung disease. Can J Cardiol 50:4 (2003), 411–414.
5. 5 Jensen, K.S., Micco, A.J., Czartolomna, J., Latham, L., Voelkel, N.F., Rapid onset of hypoxic vasoconstriction in isolated lungs. J Appl Physiol (1985) 72:5 (1992), 2018–2023.
6. 6 Grant, J.L., Naylor, R.W., Crandell, W.B., Bronchial adenoma resection with relief of hypoxic pulmonary vasoconstriction. Chest 77:3 (1980), 446–449.
7. 7 Shirai, M., Ninomiya, I., Sada, K., Constrictor response of small pulmonary arteries to acute pulmonary hypertension during left atrial pressure elevation. Jpn J Physiol 41:1 (1991), 129–142.
8. 8 Madden, J.A., Vadula, M.S., Kurup, V.P., Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am J Physiol 263:3 Pt 1 (1992), L384–L393.
9. 9 Michelakis, E.D., Hampl, V., Nsair, A., et al. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 90:12 (2002), 1307–1315.
10. 10 Yuan, X.J., Tod, M.L., Rubin, L.J., Blaustein, M.P., Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am J Physiol 259:2 Pt 2 (1990), H281–H289.
11. 11 Archer, S.L., Weir, E.K., Wilkins, M.R., Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121:18 (2010), 2045–2066.
12. 12 Archer, S.L., Will, J.A., Weir, E.K., Redox status in the control of pulmonary vascular tone. Herz 11:3 (1986), 127–141.
13. 13 Moudgil, R., Michelakis, E.D., Archer, S.L., Hypoxic pulmonary vasoconstriction. J Appl Physiol (1985) 98:1 (2005), 390–403.
14. 14 Rounds, S., McMurtry, I.F., Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs. Circ Res 48:3 (1981), 393–400.
15. 15 Weir, E.K., Archer, S.L., The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J 9:2 (1995), 183–189.
16. 16 Hong, Z., Kutty, S., Toth, P.T., et al. Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus. Circ Res 112:5 (2013), 802–815.
17. 17 Mitchell, P., Aspects of the chemiosmotic hypothesis. Biochem J 116:4 (1970), 5P–6P.
18. 18 Jonckheere, A.I., Smeitink, J.A., Rodenburg, R.J., Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis 35:2 (2012), 211–225.
19. 19 Margulis, L., Genetic and evolutionary consequences of symbiosis. Exp Parasitol 39:2 (1976), 277–349.
20. 20 Archer, S.L., Mitochondrial dynamics—mitochondrial fission and fusion in human diseases. N Engl J Med 369:23 (2013), 2236–2251.
21. 21 Michelakis, E.D., Rebeyka, I., Wu, X., et al. Oxygen sensing in the human ductus arteriosus: regulation of voltage-gated K+ channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res 91:6 (2002), 478–486.
22. 22 Michelakis, E.D., Thebaud, B., Weir, E.K., Archer, S.L., Hypoxic pulmonary vasoconstriction: redox regulation of oxygen-sensitive K+ channels by a mitochondrial oxygen-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 37:6 (2004), 1119–1136.
23. 23 Weir, E.K., Lopez-Barneo, J., Buckler, K.J., Archer, S.L., Acute oxygen-sensing mechanisms. N Engl J Med 353:19 (2005), 2042–2055.
24. 24 McMurtry, I.F., Davidson, A.B., Reeves, J.T., Grover, R.F., Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res 38:2 (1976), 99–104.
25. 25 Post, J.M., Hume, J.R., Archer, S.L., Weir, E.K., Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 262:4 Pt 1 (1992), C882–C890.
26. 26 Archer, S.L., Wu, X.C., Thebaud, B., et al. Preferential expression and function of voltage-gated, oxygen-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 95:3 (2004), 308–318.
27. 27 Hasunuma, K., Rodman, D.M., McMurtry, I.F., Effects of K+ channel blockers on vascular tone in the perfused rat lung. Am Rev Respir Dis 144:4 (1991), 884–887.
28. 28 McMurtry, I.F., BAY K 8644 potentiates and A23187 inhibits hypoxic vasoconstriction in rat lungs. Am J Physiol 249:4 Pt 2 (1985), H741–H746.
29. 29 Archer, S.L., Souil, E., Dinh-Xuan, A.T., et al. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101:11 (1998), 2319–2330.
30. 30 Firth, A.L., Remillard, C.V., Platoshyn, O., Fantozzi, I., Ko, E.A., Yuan, J.X., Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels. Pulm Circ 1:1 (2011), 48–71.
31. 31 Archer, S.L., London, B., Hampl, V., et al. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J 15:10 (2001), 1801–1803.
32. 32 Ward, J.P., Point: Hypoxic pulmonary vasoconstriction is mediated by increased production of reactive oxygen species. J Appl Physiol (1985) 101:3 (2006), 993–995 discussion 999.
33. 33 Duprat, F., Guillemare, E., Romey, G., et al. Susceptibility of cloned K+ channels to reactive oxygen species. Proc Natl Acad Sci U S A 92:25 (1995), 11796–11800.
34. 34 Gardener, M.J., Johnson, I.T., Burnham, M.P., Edwards, G., Heagerty, A.M., Weston, A.H., Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 142:1 (2004), 192–202.
35. 35 Ward, J.P., McMurtry, I.F., Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol 9:3 (2009), 287–296.
36. 36 Archer, S.L., Huang, J., Henry, T., Peterson, D., Weir, E.K., A redox-based oxygen sensor in rat pulmonary vasculature. Circ Res 73:6 (1993), 1100–1112.
37. 37 Archer, S.L., Nelson, D.P., Weir, E.K., Simultaneous measurement of oxygen radicals and pulmonary vascular reactivity in rat lung. J Appl Physiol (1985) 67:5 (1989), 1903–1911.
38. 38 Paky, A., Michael, J.R., Burke-Wolin, T.M., Wolin, M.S., Gurtner, G.H., Endogenous production of superoxide by rabbit lungs: effects of hypoxia or metabolic inhibitors. J Appl Physiol (1985) 74:6 (1993), 2868–2874.
39. 39 Chandel, N.S., McClintock, D.S., Feliciano, C.E., et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of oxygen sensing. J Biol Chem 275:33 (2000), 25130–25138.
40. 40 Guzy, R.D., Hoyos, B., Robin, E., et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1:6 (2005), 401–408.
41. 41 Waypa, G.B., Chandel, N.S., Schumacker, P.T., Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 88:12 (2001), 1259–1266.
42. 42 Waypa, G.B., Marks, J.D., Mack, M.M., Boriboun, C., Mungai, P.T., Schumacker, P.T., Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res 91:8 (2002), 719–726.
43. 43 Weir, E.K., Archer, S.L., Counterpoint: hypoxic pulmonary vasoconstriction is not mediated by increased production of reactive oxygen species. J Appl Physiol (1985) 101:3 (2006), 995–998 discussion 998.
44. 44 Thebaud, B., Wu, X.C., Kajimoto, H., et al. Developmental absence of the oxygen sensitivity of L-type calcium channels in preterm ductus arteriosus smooth muscle cells impairs oxygen constriction contributing to patent ductus arteriosus. Pediatr Res 63:2 (2008), 176–181.
45. 45 Archer, S.L., Wu, X.C., Thebaud, B., Moudgil, R., Hashimoto, K., Michelakis, E.D., O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide. Biol Chem 385:3-4 (2004), 205–216.
46. 46 Henry, T.D., Archer, S.L., Nelson, D., Weir, E.K., From, A.H., Postischemic oxygen radical production varies with duration of ischemia. Am J Physiol 264:5 Pt 2 (1993), H1478–H1484.
47. 47 Reeve, H.L., Michelakis, E., Nelson, D.P., Weir, E.K., Archer, S.L., Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol (1985) 90:6 (2001), 2249–2256.
48. 48 Nagendran, J., Stewart, K., Hoskinson, M., Archer, S.L., An anesthesiologist's guide to hypoxic pulmonary vasoconstriction: implications for managing single-lung anesthesia and atelectasis. Curr Opin Anaesthesiol 19:1 (2006), 34–43.
49. 49 Silva-Costa-Gomes, T., Gallart, L., Valles, J., Trillo, L., Minguella, J., Puig, M.M., Low- vs high-dose almitrine combined with nitric oxide to prevent hypoxia during open-chest one-lung ventilation. Br J Anaesth 95:3 (2005), 410–416.
50. 50 Bartsch, P., Maggiorini, M., Ritter, M., Noti, C., Vock, P., Oelz, O., Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 325:18 (1991), 1284–1289.
51. 51 Hackett, P.H., Creagh, C.E., Grover, R.F., et al. High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 302:19 (1980), 1070–1073.
52. 52 Hultgren, H.N., High-altitude pulmonary edema: current concepts. Ann Rev Med 47 (1996), 267–284.
53. 53 Lumb, A.B., Slinger, P., Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications. Anesthesiology 122:4 (2015), 932–946.
54. 54 Rodriguez-Roisin, R., Ballester, E., Roca, J., Torres, A., Wagner, P.D., Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation. Am Rev Respir Dis 139:3 (1989), 732–739.
55. 55 Piercy, V., Smith, H., Arch, J.R., Effects of isoprenaline, adrenaline and selective alpha 1- and alpha 2- adrenoceptor stimulation on hypoxic pulmonary vasoconstriction in rat isolated perfused lungs. Pulmon Pharmacol 3:2 (1990), 59–63.
56. 56 Knudson, R.J., Constantine, H.P., An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects. J Appl Physiol 22:3 (1967), 402–406.
57. 57 Sylvester, J.T., Shimoda, L.A., Aaronson, P.I., Ward, J.P., Hypoxic pulmonary vasoconstriction. Physiol Rev 92:1 (2012), 367–520.
58. 58 Weitzenblum, E., Kessler, R., Oswald, M., Fraisse, P., Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 7:1 (1994), 148–152.
59. 59 Melot, C., Naeije, R., Rothschild, T., Mertens, P., Mols, P., Hallemans, R., Improvement in ventilation-perfusion matching by almitrine in COPD. Chest 83:3 (1983), 528–533.
60. 60 Light, R.B., Indomethacin and acetylsalicylic acid reduce intrapulmonary shunt in experimental pneumococcal pneumonia. Am Rev Respir Dis 134:3 (1986), 520–525.
61. 61 Archer, S.L., Mike, D., Crow, J., Long, W., Weir, E.K., A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest 109:3 (1996), 750–755.
62. 62 McCormack, D.G., Paterson, N.A., Loss of hypoxic pulmonary vasoconstriction in chronic pneumonia is not mediated by nitric oxide. Am J Physiol 265:5 Pt 2 (1993), H1523–H1528.
63. 63 Dantzker, D.R., Brook, C.J., Dehart, P., Lynch, J.P., Weg, J.G., Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 120:5 (1979), 1039–1052.
64. 64 Enkhbaatar, P., Murakami, K., Shimoda, K., et al. The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Med 167:7 (2003), 1021–1026.
65. 65 Melot, C., Hallemans, R., Naeije, R., Mols, P., Lejeune, P., Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis 130:4 (1984), 612–616.
66. 66 Walmrath, D., Schermuly, R., Pilch, J., Grimminger, F., Seeger, W., Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J 10:5 (1997), 1084–1092.
67. 67 Durmowicz, A.G., Hofmeister, S., Kadyraliev, T.K., Aldashev, A.A., Stenmark, K.R., Functional and structural adaptation of the yak pulmonary circulation to residence at high altitude. J Appl Physiol (1985) 74:5 (1993), 2276–2285.
68. 68 Newman, J.H., Holt, T.N., Hedges, L.K., et al. High-altitude pulmonary hypertension in cattle (brisket disease): candidate genes and gene expression profiling of peripheral blood mononuclear cells. Pulm Circ 1:4 (2011), 462–469.
69. 69 Glover, G.H., Newsou, L., Further studies on brisket disease. J Agricultural Res, 15(0), 1918, 409.
70. 70 Grover, R.F., Pulmonary circulation in animals and man at high altitude. Ann NY Acad Sci 127:1 (1965), 632–639.
71. 71 Anand, I.S., Harris, E., Ferrari, R., Pearce, P., Harris, P., Pulmonary haemodynamics of the yak, cattle, and cross breeds at high altitude. Thorax 41 (1986), 696–700.
72. 72 Will, D.H., Hicks, J.L., Card, C.S., Alexander, A.F., Inherited susceptibility of cattle to high-altitude pulmonary hypertension. J Appl Physiol 38:3 (1975), 491–494.
73. 73 Newman, J.H., Holt, T.N., Cogan, J.D., et al. Increased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension. Nature Commun, 6, 2015, 6863.
74. 74 Groves, B.M., Droma, T., Sutton, J.R., et al. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J Appl Physiol (1985) 74:1 (1993), 312–318.
75. 75 Peñaloza, D., Sime, F., Banchero, N., Gamboa, R., Cruz, J., Marticorena, E., Pulmonary hypertension in healthy men born and living at high altitudes. Am J Cardiol 11:2 (1963), 150–157.
76. 76 Bhagi, S., Srivastava, S., Singh, S.B., High-altitude pulmonary edema: review. J Occup Health 56:4 (2014), 235–243.
77. 77 Bartsch, P., Mairbaurl, H., Swenson, E.R., Maggiorini, M., High altitude pulmonary oedema. Swiss Med Wkly 133:27-28 (2003), 377–384.
78. 78 Dehnert, C., Mereles, D., Greiner, S., et al. Exaggerated hypoxic pulmonary vasoconstriction without susceptibility to high altitude pulmonary edema. High Alt Med Biol 16:1 (2015), 11–17.
79. 79 Deem, S., Hedges, R.G., Kerr, M.E., Swenson, E.R., Acetazolamide reduces hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs. Respir Physiol 123:1-2 (2000), 109–119.
80. 80 Maggiorini, M., High altitude-induced pulmonary oedema. Cardiovasc Res 72:1 (2006), 41–50.
81. 81 Oelz, O., Maggiorini, M., Ritter, M., et al. Nifedipine for high altitude pulmonary oedema. Lancet 2:8674 (1989), 1241–1244.
82. 82 Ang, S.O., Chen, H., Hirota, K., et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:4 (2002), 614–621.
83. 83 Hickey, M.M., Richardson, T., Wang, T., et al. The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J Clin Invest 120:3 (2010), 827–839.
84. 84 Smith, T.G., Brooks, J.T., Balanos, G.M., et al. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med, 3(7), 2006, e290.
85. 85 Archer, S.L., Marsboom, G., Kim, G.H., et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121:24 (2010), 2661–2671.
86. 86 Jin, W.S., Kong, Z.L., Shen, Z.F., Jin, Y.Z., Zhang, W.K., Chen, G.F., Regulation of hypoxia inducible factor-1alpha expression by the alteration of redox status in HepG2 cells. J Exp Cancer Res, 30, 2011, 61.
87. 87 Archer, S.L., Gomberg-Maitland, M., Maitland, M.L., Rich, S., Garcia, J.G., Weir, E.K., Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 oxygen-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 294:2 (2008), H570–H578.